Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05795218Terminated

directSTIM™ Deep Brain Stimulation System Post-Market Clinical Follow-up Study on Essential Tremor

Role: lead

NCT04329676Not ApplicableUnknown

directSTIM Deep Brain Stimulation System Study

Role: lead

NCT02894567Not ApplicableTerminated

Evaluation of Directional Recording and Stimulation Using spiderSTN

Role: lead

NCT01764815Not ApplicableCompleted

Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) Leads

Role: lead

All 4 trials loaded